Lars Backman - Biotage AB Vice President of Corporate Development
| BITGF Stock | USD 16.87 0.00 0.00% |
President
Mr. Lars Backman was Vice President Corporationrationrate Development at Biotage AB since January 2007. Prior to joining the Company, he held the position of Senior Vice President of Corporationrationrate Development at Affibody. He has previous experience as a lawyer at the Swedish law firm Hamilton Co, specialized in Corporationrationrate Finance and Mergers Acquisitions, and from Venture Management at the Business Development firm Googol. He is Member of the Board of Chreto ApS since 2007.
| Age | 57 |
| Tenure | 17 years |
| Phone | 46 18 56 59 00 |
| Web | https://www.biotage.com |
Biotage AB Management Efficiency
The company has return on total asset (ROA) of 0.109 % which means that it generated a profit of $0.109 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1785 %, meaning that it generated $0.1785 on every $100 dollars invested by stockholders. Biotage AB's management efficiency ratios could be used to measure how well Biotage AB manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | PRESIDENT Age | ||
| John Stratton | Verizon Communications | 55 | |
| Roger Gurnani | Verizon Communications | 55 | |
| Raghu Krishnamoorthy | GE Aerospace | 57 | |
| Robert Davis | Merck Company | 54 | |
| Jonathan Headley | Walt Disney | N/A | |
| Marc Gordon | American Express | 59 | |
| Chris Bartlett | Verizon Communications | N/A | |
| Paul Abbott | American Express | N/A | |
| Paul Fabara | American Express | 52 | |
| Caroline Litchfield | Merck Company | 55 | |
| Christine McCarthy | Walt Disney | 69 | |
| Jim Scholefield | Merck Company | 55 | |
| Richard DeLuca | Merck Company | 61 | |
| Kyle Malady | Verizon Communications | 55 | |
| Linda Zukauckas | American Express | N/A | |
| Michael Holston | GE Aerospace | 62 | |
| Michael Rosenblatt | Merck Company | 67 | |
| Denise Pickett | American Express | 55 | |
| Daniel Mead | Verizon Communications | 60 | |
| Luke Kang | Walt Disney | 50 | |
| Rick Petrino | American Express | N/A | |
Management Performance
| Return On Equity | 0.18 | |||
| Return On Asset | 0.11 |
Biotage AB Leadership Team
Elected by the shareholders, the Biotage AB's board of directors comprises two types of representatives: Biotage AB inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Biotage. The board's role is to monitor Biotage AB's management team and ensure that shareholders' interests are well served. Biotage AB's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Biotage AB's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Karolina Lawitz, Member of the Board of Directors | ||
| NilsOlof Bjork, Director | ||
| Love Amcoff, Director, Employee Representative | ||
| Thomas Eklund, Member of the Board of Directors | ||
| Rikke Rytter, Vice President Global Marketing | ||
| Mark Bradley, Director | ||
| Ove Mattsson, Chairman of the Board of Directors | ||
| Cecilia Hallner, Global Human Resources Director | ||
| Malin Albertsson, Director, Employee Representative | ||
| Erika Johnson, CFO | ||
| Petra Duprez, Chief Officer | ||
| Jonas Stahlberg, Chief Auditor | ||
| Raffaella Bombarda, EVP Marketing | ||
| Yvonne Martensson, Director | ||
| Steve Jordan, Chief Scientific Officer | ||
| Anders Wikstrom, Vice President - Operations | ||
| Lars Backman, Vice President of Corporate Development | ||
| Anders Walldov, Member of the Board of Directors | ||
| Scott Carr, Pres Americas | ||
| Tomas Blomquist, CEO Pres | ||
| Peter Ehrenheim, Member of the Board of Directors | ||
| Torben Joergensen, President and CEO | ||
| Maja Nilsson, Chief Officer | ||
| CS BSc, Ex Operations | ||
| Paul Belton, Vice President - Business Development | ||
| JonSverre Schanche, Chief Officer | ||
| Olof Nord, Exec Devel | ||
| Lars LLB, Chief Officer | ||
| Annika Gardlund, Director, Employee Representative |
Biotage Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Biotage AB a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.18 | |||
| Return On Asset | 0.11 | |||
| Profit Margin | 0.16 % | |||
| Current Valuation | 1.17 B | |||
| Shares Outstanding | 65.98 M | |||
| Shares Owned By Insiders | 0.58 % | |||
| Shares Owned By Institutions | 64.57 % | |||
| Price To Earning | 47.58 X | |||
| Price To Book | 6.36 X | |||
| Price To Sales | 6.61 X |
Pair Trading with Biotage AB
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biotage AB position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotage AB will appreciate offsetting losses from the drop in the long position's value.Moving together with Biotage OTC Stock
| 0.74 | GOOG | Alphabet Class C Aggressive Push | PairCorr |
| 0.64 | AMZN | Amazon Inc Earnings Call This Week | PairCorr |
Moving against Biotage OTC Stock
| 0.83 | MCD | McDonalds Earnings Call This Week | PairCorr |
| 0.74 | JNJ | Johnson Johnson Aggressive Push | PairCorr |
| 0.74 | BA | Boeing Financial Report 24th of July 2024 | PairCorr |
| 0.71 | INTC | Intel Earnings Call Tomorrow | PairCorr |
| 0.64 | AAPL | Apple Inc Earnings Call Next Week | PairCorr |
The ability to find closely correlated positions to Biotage AB could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biotage AB when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biotage AB - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biotage AB to buy it.
The correlation of Biotage AB is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biotage AB moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biotage AB moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biotage AB can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biotage AB. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Biotage AB information on this page should be used as a complementary analysis to other Biotage AB's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Complementary Tools for Biotage OTC Stock analysis
When running Biotage AB's price analysis, check to measure Biotage AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotage AB is operating at the current time. Most of Biotage AB's value examination focuses on studying past and present price action to predict the probability of Biotage AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotage AB's price. Additionally, you may evaluate how the addition of Biotage AB to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |